Personalized medicine is transforming healthcare.

With the ability to optimize treatment based on the molecular characterization of the patient’s disease, it offers unprecedented global opportunities for product developers and service providers to deliver value to healthcare providers.

Emerging technologies are impacting how new treatments are developed even as the application of genomics and other biomarker information to clinical medicine rapidly evolves and changes patient care.

Personalized Medicine Partners brings together leaders in the scientific, medical and business disciplines to create health-economic value in this emerging field.

Whether it’s identifying unmet medical needs, translating scientific breakthroughs into medical products or creating novel business models, PMP serves as a catalyst for creating value-added personalized medicine products and services.